Source: T09
Original URL: https://www.eirgenix.com/antibody-drug-conjugate
Title: EirGenix — ADC & Bioconjugates
Original source_date: unknown
Original data_date: unknown
Checked_at: 2026-10-07T10:46:10.944263+00:00
Timezone: Etc/UTC
Retrieval mode: live_public_web_tool
Read level: targeted_public_HTML_passages
Access result: specified public URL returned readable content; no access barrier encountered
Material type: minimum excerpt/numeric-support record authored from the observed public source, not the full original webpage/PDF.
The SHA256 of this .txt identifies this excerpt record only. Original webpage/PDF bytes were not saved.
Locators:
- ADC & Bioconjugates / partner: web lines 87–95
- Monoclonal Antibody Development and Production / High Potency Chemicals / Linkers: web lines 109–125
Minimum verbatim excerpts:
- web line 88: our strategic partner, Formosa Laboratories, Inc.
- web line 110: both non-GMP and GMP-level manufacturing
- web line 110: compatibility studies across antibodies, intermediates, payloads, and linkers
Numeric / structured original fields (not market estimates):
Supported scope (author paraphrase, not original quotation):
台康公開頁列台耀為策略夥伴，描述抗體、分析／品質、GMP製造與偶聯相關整合服務；支持對外能力與合作配置。
Precise evidence gap / boundary:
頁面未標資料日；不能由服務頁推定特定ADC商業訂單、客戶批次已放行或收入。未採過時的ADC核准總數或其他槽體尺度。
Web references: turn115view3